CBTNYSEMiscellaneous Chemical ProductsFiscal year ends September 30
CABOT CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$73.46−0.83 (-1.12%)
Close on Oct 19, 2026
- Market cap
- $3.81B
- P/E (TTM)
- 13.6
- Dividend yield
- 2.40%
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
25.3%+6.2 pts over 5 years
Operating margin
16.7%+15.9 pts over 5 years
Net margin
8.9%+18.0 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -7.0% | -4.9% | +7.3% | +2.6% | |
| Gross profit | -2.1% | +2.0% | +13.5% | +4.9% | |
| Operating income | +1.1% | +16.9% | +96.9% | – | |
| Net income | -12.9% | +16.6% | – | – | |
| EPS, diluted | -10.4% | +18.5% | – | – | |
| Free cash flow | -13.3% | – | +17.2% | +0.9% | |
| Dividend per share | +6.0% | +5.9% | +4.7% | +7.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 11.7% | -28.2% | 22.3% | |
| Return on assets | 4.8% | -8.2% | 8.8% | |
| Current ratio | 2.64 | 1.85 | 1.61 | |
| Debt to equity | 0.72 | 1.61 | 0.73 | |
| Net debt to EBITDA | 1.77× | 5.39× | 1.13× | |
| Interest coverage | 4.6× | 0.4× | 8.2× | |
| Inventory turnover | 5.0× | 5.1× | 5.3× | |
| Capex to revenue | 4.6% | 7.7% | 7.4% | |
| Diluted shares | 63M | 57M | 54M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Cabot generated $2.31B from operations and spent $2.10B on capital expenditure, dividends and share buybacks. 55% of that went back into the business.
Generated
$2.31B
Used
$2.10B
Capital expenditure$1.17B55%Dividends$441.00M21%Share buybacks$494.00M24%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin8.9%
×Asset turnover0.98×
×Equity multiplier2.54×
=Return on equity, FY202522.3%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 8.9% | 0.98× | 2.54× | 22.3% |
| FY2024 | 9.5% | 1.09× | 2.73× | 28.3% |
| FY2023 | 11.3% | 1.10× | 3.30× | 41.2% |
| FY2022 | 4.8% | 1.27× | 3.70× | 22.7% |
| FY2021 | 7.3% | 1.12× | 3.72× | 30.5% |
| FY2020 | -9.1% | 0.90× | 3.43× | -28.2% |
| FY2019 | 4.7% | 1.07× | 2.90× | 14.6% |
| FY2018 | -3.5% | 0.99× | 2.48× | -8.5% |
| FY2017 | 9.1% | 0.85× | 2.30× | 17.9% |
| FY2016 | 6.1% | 0.79× | 2.44× | 11.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$331.00M
- Cash generatingOperating cash flow above zero$665.00M
- Return on assets improvedROA up on the prior year10.5% → 8.9%
- Earnings backed by cashOperating cash flow above net income$665.00M vs $331.00M
- Less leverageLong-term debt to assets fell29.1% → 22.4%
- Better liquidityCurrent ratio rose2.08 → 1.61
- No dilutionShare count did not rise56M → 54M
- Gross margin improvedGross margin up on the prior year24.04% → 25.32%
- More efficientAsset turnover rose1.11 → 0.99